Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327 (26 July), doi:10.1136/bmj.327.7408.0-d
Research in palliative care settings needs novel approaches. As obtaining fully informed consent is usually impossible, research on drugs that could benefit dying patients is particularly difficult. Rees and Hardy (p 198) have developed a novel advance consent process to support a trial comparing two of the drugs commonly used for the control of "death rattle." If generally accepted, this may facilitate the research necessary to advance the care of dying patients.
|
|
Credit: JUNEBUG CLARK/SPL
|
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?